Obama signs FDA user fee bill

July 9, 2012 by MassDevice staff

President Barack Obama signs the Food & Drug Administration Safety & Innovation Act, enacting the doubling of the user fees medical device companies pay to have the FDA review their products.

MassDevice.com news

President Barack Obama put his pen to the Food & Drug Administration Safety & Innovation Act today, making it the law of the land that the user fees medical device companies pay to have the FDA review their products more than doubles.

The med-tech industry and the federal watchdog agency spent months hashing out the terms of the deal, which ultimately boosted the user fees from $295 million over 5 years to $595 million, in exchange for the FDA meeting performance goals.

The White House signed off on the agreement in March, setting the stage for wrangling in and between the House and Senate before the upper chamber approved a reconciled bill June 25.

Sign up to get our free newsletters delivered right to your inbox.

"We commend the president and the bipartisan efforts of Congress to enact this legislation, which is an important step toward maintaining a transparent and efficient FDA review process that will foster the development of innovative technologies," said Gail Rodriguez, executive director of the Medical Imaging & Technology Alliance, in prepared remarks.

Steve Ubl, CEO of med-tech industry lobby AdvaMed, was quick to laud the new user fee regime as an evolutionary step forward.

Comments